Nat Re underwriting profits rise on lower non-life losses
June 14 2021 by InsuranceAsia News
-
Opinion: Will generative AI be a game-changer when it comes to risk modelling?
- November 22
Algorithms can, in theory, be trained to create predictive models to analyse satellite imagery of cat-affected regions across Asia or forecast a typhoon’s trajectory as well as estimate potential damage and identify high-risk areas.
-
1.1 property renewals to be stable, casualty rates may harden: AM Best
- November 21
The outlook for the segment remains positive, however, adverse reserve developments weigh on the liability market.
-
Interest in standalone renewable treaties in APAC remains strong: Gallagher Re
- November 21
There is rate adequacy in the market ahead of the 2025 renewal season as costs have stabilised in the reinsurance market, according to a whitepaper on renewable energy by the reinsurance broker.
-
UIB Group expands Asia footprint with representative office in Nepal
- November 20
The Kathmandu office will report to the UIB Asia regional headquarters based in Singapore.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
